We only have this paper's title and publication details.
Read it at the sourceIn vitro analysis shows HR-19011 inhibits hematologic malignancies by activating the HRI-eIF2α-ATF4 pathway, indicating potential therapeutic avenues.
In vitro kinase assay demonstrating that HR-19011 does not directly activate HRI
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: